-
Do all women with lymph node-positive breast cancer treated with neoadjuvant chemotherapy need to have all of their axillary nodes surgically removed? The answer seems to depend on whom you ask. For example, Judy Boughey, MD, a surgical oncologist from […]
read more -
An FDA review has identified a possible link between breast implants and a rare form of non-Hodgkin’s lymphoma. The review uncovered about three dozen cases of anaplastic large-cell lymphoma (ALCL) in women with breast implants. Most of the cases […]
read more -
LONDON (Reuters) – A British-led petition signed by 29,000 people has demanded that Switzerland’s Roche, the world’s biggest maker of cancer medicines, cut the price of its expensive new breast cancer drug Kadcyla. The campaign shows the growing pressure […]
read more -
NEW YORK (Reuters Health) – Women who had radiotherapy for Wilms tumor face an increased risk of early breast cancer, according to results from National Wilms Tumor Late Effects Study. “While we had expected to observe an increase in […]
read more -
One of every seven women who undergo annual mammography screening for breast cancer will be called back for follow-up tests. These women can worry for days or weeks that the “suspicious” finding the radiologist has seen on their mammogram […]
read more -
NEW YORK (Reuters Health) – Rates of recurrence of ductal carcinoma in situ (DCIS) after breast-conserving surgery (BCS) remain lower 20 years after radiotherapy, according to results from the SweDCIS Trial. “Today in Sweden, according to our national guidelines […]
read more -
Postmenopausal women with a more diverse population of gut bacteria may be more efficient at breaking down estrogen, a new study suggests. Because estrogen plays a role in causing breast cancer, researchers speculate a healthy bacterial population may lower the […]
read more -
Prediabetes — even at lower levels of impaired fasting glucose (IFG) as defined by the American Diabetes Association (ADA) — is associated with a significant increase in cancer risk that is independent of the effects of obesity, according to the […]
read more -
In recent years, several observational studies have suggested that the bone-targeting bisphosphonate drugs may also have a protective effect against breast cancer, but a new analysis of data from randomized clinical trials has found no such effect. The new […]
read more -
NEW YORK (Reuters Health) – A new statistical analysis finds that women under age 50 who were diagnosed with breast cancer were also more likely to have recently been using oral contraceptives. The increased cancer risk still translates to […]
read more
